Update 07:38 AM EDT, 04/29/2022 (MT Newswires) -- Skylight Health Group Inc. (SLHG.V), a multi-state primary care management group in the United States, on Friday provided an update on the status of its research program; Skylight Health Research.
In April 2021, Skylight Health Research announced its partnership with ClinEdge to launch formal clinical research studies into its practices. Since then, it has been awarded 10 clinical studies and has completed two to-date. The 10 studies awarded will advance knowledge of COVID-19, influenza patterns, cancer detection, major depressive disorder, and Lyme disease.Total revenue earned through clinical studies in 2021, $300,000, has already been surpassed in 2022, and is expected to quadruple by the end of this year, the company added.
Skylight Health Research has also made several other key partnerships with research partners and Contract Research Organizations that will bring a steady supply of study opportunities to Skylight Health practices.